Elsevier

Experimental Cell Research

Volume 209, Issue 2, December 1993, Pages 231-237
Experimental Cell Research

Regular Article
Investigation of the Role of G1/S Cell Cycle Mediators in Cellular Senescence

https://doi.org/10.1006/excr.1993.1306Get rights and content

Abstract

Cellular senescence is a state of irreversible cell cycle arrest in which normal cells at the end of their lifespan fail to enter into DNA synthesis upon serum or growth factor stimulation. We examined whether proteins required for G1/S cell cycle progression were irreversibly down-regulated in senescent human fibroblasts. Both the 44- and 42-kDa forms of the MAP-kinase protein were expressed at similar levels in young and senescent cells. In contrast to young cells where both forms were phosphorylated on tyrosine in response to serum, the p42MAP-kinase was not tyrosine phosphorylated upon serum stimulation, whereas p44MAP-kinase was phosphorylated on tyrosine in serum-starved or serum-stimulated senescent cells. Examination of p53 protein in growing, quiescent, and senescent cells revealed no significant differences in levels between the different growth states. In contrast, cdk2 and cyclin A mRNAs were completely down-regulated in stimulated senescent fibroblasts, while the G1 cyclins, C, D1, and E mRNAs, were still expressed in stimulated senescent cells although at reduced levels compared to young cells. The expression of early G1 markers, but not late G1 markers, indicates that senescent cells may be blocked at a point in late G1. We investigated whether transfection of cyclin A, alone or in combination with cdc2, was sufficient for extension of lifespan or escape from senescence. Clones expressing the transfected human cyclin A or cdc2 genes senesced at a population doubling similar to controls, thereby showing that cyclin A or cdc2 expression alone was insufficient for escape from senescence.

References (0)

Cited by (105)

  • Redox control of senescence and age-related disease

    2017, Redox Biology
    Citation Excerpt :

    Cellular senescence, also termed replicative senescence, was first proposed four decades ago [31,32] and has since been proven to be a significant tumor constraining mechanism that halts the proliferation of primary mammalian cells after a finite number of population doublings [33–37] allowing the organism to antagonize the potentially detrimental effects of uncontrolled growth. Proliferation is checked by persistently arresting cell growth at the G1- [38–42], G2- [43–45], G2/M- [46] or S-phase of the cell cycle leading to failure of DNA replication. So far, senescence-associated growth arrest has been shown to depend functionally on the tumor- suppressor pathways controlled by p16INK4a and pRB (retinoblastoma protein), as well as by p53.

  • Luotonin-A based quinazolinones cause apoptosis and senescence via HDAC inhibition and activation of tumor suppressor proteins in HeLa cells

    2015, European Journal of Medicinal Chemistry
    Citation Excerpt :

    Cellular senescence is a final common pathway for a number of DNA damage and repair pathways and appears to play a major role in processes such as aging, stress and tumor suppression [52] and is characterized by morphological changes such as blue coloration and adopted a fattened morphology with spread out cytoplasm as observed in senescence associated β-galactosidase (SA-β-gal) staining [53]. Previous studies have indicated that strong irreversible G1 cell cycle arrest might be responsible for senescence phenotype in cancer cells [54,55]. This prompted us to examine senescence as a part of tumor-suppressive mechanism in compound treated cells [56].

  • MAP kinase: It's been longer than fifteen minutes

    2008, Biochemical and Biophysical Research Communications
    Citation Excerpt :

    Defects in ERK1 versus ERK2 activation in senescence suggest divergent functions. Serum stimulates tyrosine phosphorylation of ERK2 in young MRC-5 cells, but not in senescent MRC-5 cells [53]. These are older observations that require reexamination.

View all citing articles on Scopus
View full text